Compare PR & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PR | DGX |
|---|---|---|
| Founded | 2015 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5B | 23.2B |
| IPO Year | 2016 | 1996 |
| Metric | PR | DGX |
|---|---|---|
| Price | $23.83 | $240.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 13 |
| Target Price | $22.35 | ★ $214.38 |
| AVG Volume (30 Days) | ★ 9.7M | 749.7K |
| Earning Date | 05-06-2026 | 04-21-2026 |
| Dividend Yield | ★ 2.96% | 1.82% |
| EPS Growth | N/A | ★ 13.78 |
| EPS | 0.99 | ★ 5.08 |
| Revenue | $5,065,211,000.00 | ★ $11,035,000,000.00 |
| Revenue This Year | $20.94 | $7.53 |
| Revenue Next Year | $7.51 | $3.77 |
| P/E Ratio | ★ $24.03 | $46.50 |
| Revenue Growth | 1.29 | ★ 11.78 |
| 52 Week Low | $11.92 | $171.18 |
| 52 Week High | $24.09 | $247.19 |
| Indicator | PR | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 65.18 | 58.67 |
| Support Level | $19.34 | $190.40 |
| Resistance Level | $24.09 | N/A |
| Average True Range (ATR) | 0.60 | 4.69 |
| MACD | 0.03 | -1.26 |
| Stochastic Oscillator | 92.56 | 53.74 |
Permian Resources Corp is an independent oil and natural gas company focused on generating outsized returns to stakeholders through the responsible acquisition, optimization, and development of oil and liquids-rich natural gas assets. The Company's assets and operations are concentrated in the core of the Permian Basin, and its properties consist of large, contiguous acreage blocks located in West Texas and New Mexico.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.